{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:44:25Z","timestamp":1778643865739,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/ijcp.13004","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T14:22:37Z","timestamp":1504534957000},"page":"e13004","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for<i>Helicobacter pylori<\/i>infection"],"prefix":"10.1155","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9059-8602","authenticated-orcid":false,"given":"Ignasi","family":"Puig","sequence":"first","affiliation":[{"name":"Digestive Diseases Unit; Althaia Xarxa Assistencial Universit\u00e0ria de Manresa; Barcelona Spain"},{"name":"Universitat Internacional de Catalunya; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas M.","family":"Gonz\u00e1lez-Santiago","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hospital Cl\u00ednico Universitario; Salamanca Spain"},{"name":"Biomedical Research Institute of Salamanca (IBSAL); Salamanca Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Molina-Infante","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hospital San Pedro de Alcantara; C\u00e1ceres Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Barrio","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hospital Rio Hortega; Valladolid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Herranz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Complejo Asistencial de \u00c1vila; \u00c1vila Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Algaba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hospital Universitario de Fuenlabrada; Fuenlabrada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hospital de Valme; Sevilla Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Madrid Spain"},{"name":"Gastroenterology Unit; Hospital Universitario de La Princesa; Instituto de Investigaci\u00f3n Sanitaria Princesa (IIS-IP); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de enfermedades Hep\u00e1ticas y Digestivas (CIBERehd); Madrid Spain"},{"name":"Digestive Diseases Unit; Corporaci\u00f3 Sanitaria Universit\u00e0ria Parc Taul\u00ed; Sabadell Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"10.1111\/ijcp.13004-BIB0001|ijcp13004-cit-0001","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13004-BIB0002|ijcp13004-cit-0002","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","article-title":"Helicobacter pylori infection and gastric lymphoma","volume":"330","author":"Parsonnet","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13004-BIB0003|ijcp13004-cit-0003","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13004-BIB0004|ijcp13004-cit-0004","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.13004-BIB0005|ijcp13004-cit-0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection - The Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1111\/ijcp.13004-BIB0006|ijcp13004-cit-0006","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/jac\/dkv155","article-title":"Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection","volume":"70","author":"Lopez-Gongora","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/ijcp.13004-BIB0007|ijcp13004-cit-0007","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1756283X15621229","article-title":"Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection","volume":"9","author":"Puig","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1111\/ijcp.13004-BIB0008|ijcp13004-cit-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2009.00738.x","article-title":"Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition","volume":"15","author":"Asaka","year":"2010","journal-title":"Helicobacter"},{"key":"10.1111\/ijcp.13004-BIB0009|ijcp13004-cit-0009","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2036.2012.05137.x","article-title":"High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates","volume":"36","author":"Sanchez-Delgado","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ijcp.13004-BIB0010|ijcp13004-cit-0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3349\/ymj.1996.37.4.270","article-title":"Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection","volume":"37","author":"Lee","year":"1996","journal-title":"Yonsei Med J"},{"key":"10.1111\/ijcp.13004-BIB0011|ijcp13004-cit-0011","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","article-title":"Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia","volume":"339","author":"McColl","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1111\/ijcp.13004-BIB0012|ijcp13004-cit-0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/annonc\/8.suppl_2.S37","article-title":"Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies","volume":"8","author":"Montalban","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1111\/ijcp.13004-BIB0013|ijcp13004-cit-0013","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/gut.42.2.166","article-title":"Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication","volume":"42","author":"Hulst","year":"1998","journal-title":"Gut"},{"key":"10.1111\/ijcp.13004-BIB0014|ijcp13004-cit-0014","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ijcp.13004-BIB0015|ijcp13004-cit-0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2012.05211.x","article-title":"Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection","volume":"36","author":"McNicholl","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ijcp.13004-BIB0016|ijcp13004-cit-0016","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/ijcp.13004-BIB0017|ijcp13004-cit-0017","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1111\/ijcp.13004-BIB0018|ijcp13004-cit-0018","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2362.2008.01951.x","article-title":"Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures","volume":"38","author":"Hsu","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/ijcp.13004-BIB0019|ijcp13004-cit-0019","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10620-013-2900-x","article-title":"Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection","volume":"59","author":"Gisbert","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1111\/ijcp.13004-BIB0020|ijcp13004-cit-0020","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.3748\/wjg.v18.i33.4542","article-title":"Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection","volume":"18","author":"Sereni","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1111\/ijcp.13004-BIB0021|ijcp13004-cit-0021","first-page":"133","article-title":"Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection","volume":"21","author":"Tursi","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1111\/ijcp.13004-BIB0022|ijcp13004-cit-0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1572-0241.2006.00457.x","article-title":"Third-line rescue therapy with levofloxacin after two H. pylori treatment failures","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/ijcp.13004-BIB0023|ijcp13004-cit-0023","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1590-8658(03)00059-8","article-title":"A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication","volume":"35","author":"Zullo","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1111\/ijcp.13004-BIB0024|ijcp13004-cit-0024","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/hel.12147","article-title":"Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori","volume":"19","author":"Lim","year":"2014","journal-title":"Helicobacter"},{"key":"10.1111\/ijcp.13004-BIB0025|ijcp13004-cit-0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1440-1746.2006.04375.x","article-title":"Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments","volume":"22","author":"Gonzalez Carro","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/ijcp.13004-BIB0026|ijcp13004-cit-0026","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore","year":"2016","journal-title":"Gut"},{"key":"10.1111\/ijcp.13004-BIB0027|ijcp13004-cit-0027","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12296","article-title":"Rifabutin containing triple therapy and rifabutin with bismuth containing quadruple therapy for third-line treatment of Helicobacter pylori infection: two pilot studies","author":"Ciccaglione","year":"2016","journal-title":"Helicobacter"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.13004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.13004\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T18:11:01Z","timestamp":1719425461000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.13004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.13004","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}